VICO

COM:VICOREPHARMA

Vicore Pharma Holding AB

  • Stock

Last Close

7.91

25/11 09:39

Market Cap

2.17B

Beta: -

Volume Today

52.06K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-5.34M
-
-4.54M
14.93%
-6.65M
46.36%
-12.79M
92.40%
-41.59M
225.07%
-94.01M
126.07%
-149.54M
59.06%
-294.82M
97.15%
-290.73M
1.39%
-310.94M
6.95%
depreciation and amortization
36K
-
6K
83.33%
6K
0%
7K
16.67%
7K
0%
1.34M
19,014.29%
3.54M
164.35%
3.60M
1.72%
3.61M
0.39%
65.98M
1,726.58%
deferred income tax
-4.59K
-
-8.20K
78.73%
1.56K
119.06%
-4.87K
411.71%
stock based compensation
4.59K
-
8.20K
78.73%
-1.56K
119.06%
4.87K
411.71%
change in working capital
2.16M
-
838K
61.19%
-605K
172.20%
276K
145.62%
8.04M
2,811.96%
3.56M
55.73%
22.68M
537.46%
27.07M
19.36%
-20.94M
177.35%
-10.65M
49.16%
accounts receivables
234K
-
-3.87M
1,752.56%
-340K
91.21%
-1.60M
370%
-2.69M
68.59%
inventory
accounts payables
3.32M
-
26.55M
698.68%
27.41M
3.26%
-19.34M
170.56%
-7.95M
58.89%
other working capital
other non cash items
320K
-
17K
94.69%
-3K
117.65%
4.80M
160,266.67%
506K
89.47%
2.12M
318.77%
3.38M
59.75%
-1.02M
130.25%
8.13M
894.34%
6.03M
25.88%
net cash provided by operating activities
-2.83M
-
-3.68M
30.34%
-7.25M
96.93%
-7.71M
6.26%
-33.04M
328.76%
-87.00M
163.35%
-119.94M
37.86%
-265.17M
121.10%
-299.92M
13.10%
-249.58M
16.78%
investments in property plant and equipment
-9.49M
-
-5.66M
40.39%
-13.48M
138.24%
-20.23M
50.13%
-2M
90.12%
-147K
92.65%
-3M
1,940.82%
-3M
-
acquisitions net
7.10M
-
20.26M
-
3M
-
purchases of investments
-500K
-
-2.54M
409%
-3.23M
26.84%
-77M
2,285.38%
-70M
9.09%
-77M
10%
-199.04M
-
sales maturities of investments
2M
-
77M
-
70M
9.09%
77M
10%
54.58M
29.11%
other investing activites
-2M
-
-3M
-
net cash used for investing activites
-2.39M
-
-5.66M
136.69%
-13.98M
147.07%
-22.78M
62.97%
15.03M
165.98%
-77.15M
613.29%
4M
105.18%
-7M
275%
74M
1,157.14%
-144.46M
295.21%
debt repayment
-7.10M
-
common stock issued
32.80M
-
319K
99.03%
50.24M
15,647.96%
232.42M
362.66%
134.83M
41.99%
187.55M
39.10%
336M
79.15%
200M
40.48%
470.92M
135.46%
common stock repurchased
dividends paid
other financing activites
-13.74M
-
-7.79M
43.36%
-10.58M
35.94%
-17.82M
68.35%
-12.96M
27.26%
-63K
99.51%
net cash used provided by financing activities
-7.10M
-
32.80M
562.03%
319K
99.03%
50.24M
15,647.96%
218.68M
335.30%
127.04M
41.90%
176.97M
39.30%
318.18M
79.80%
187.04M
41.22%
470.86M
151.74%
effect of forex changes on cash
-431K
-
1.48M
444.08%
net change in cash
-12.31M
-
23.46M
290.54%
-20.91M
189.11%
19.75M
194.47%
200.67M
915.89%
-37.10M
118.49%
61.03M
264.50%
45.58M
25.32%
-37.40M
182.04%
76.82M
305.42%
cash at beginning of period
14.03M
-
1.71M
87.81%
25.18M
1,372.22%
4.27M
83.05%
24.02M
463.03%
224.69M
835.46%
187.59M
16.51%
248.62M
32.54%
294.20M
18.33%
256.80M
12.71%
cash at end of period
1.71M
-
25.18M
1,372.22%
4.27M
83.05%
24.02M
463.03%
224.69M
835.46%
187.59M
16.51%
248.62M
32.54%
294.20M
18.33%
256.80M
12.71%
333.62M
29.91%
operating cash flow
-2.83M
-
-3.68M
30.34%
-7.25M
96.93%
-7.71M
6.26%
-33.04M
328.76%
-87.00M
163.35%
-119.94M
37.86%
-265.17M
121.10%
-299.92M
13.10%
-249.58M
16.78%
capital expenditure
-9.49M
-
-5.66M
40.39%
-13.48M
138.24%
-20.23M
50.13%
-2M
90.12%
-147K
92.65%
-3M
1,940.82%
-3M
-
free cash flow
-12.31M
-
-9.34M
24.17%
-20.73M
121.95%
-27.94M
34.78%
-35.04M
25.41%
-87.15M
148.73%
-122.94M
41.07%
-265.17M
115.70%
-302.92M
14.24%
-249.58M
17.61%

All numbers in (except ratios and percentages)